Header Logo

Connection

Alan Landay to HIV

Back to Details
This is a "connection" page, showing publications Alan Landay has written about HIV.
Alan Landay
Connection Strength
3.356
HIV
  1. Regulatory B cells inhibit cytotoxic T lymphocyte (CTL) activity and elimination of infected CD4 T cells after in vitro reactivation of HIV latent reservoirs. PLoS One. 2014; 9(4):e92934.
    View in: PubMed
    Score: 0.451
  2. Positive association between HIV RNA and IL-6 in the genital tract of Rwandan women. AIDS Res Hum Retroviruses. 2008 Jul; 24(7):973-6.
    View in: PubMed
    Score: 0.302
  3. Antigen-presenting cells in HIV pathogenesis and therapy: summary of the October 17-18, 2002, Think Tank meeting. Clin Immunol. 2002 Jun; 103(3 Pt 1):243-8.
    View in: PubMed
    Score: 0.198
  4. The Hitchhiker Guide to CD4+ T-Cell Depletion in Lentiviral Infection. A Critical Review of the Dynamics of the CD4+ T Cells in SIV and HIV Infection. Front Immunol. 2021; 12:695674.
    View in: PubMed
    Score: 0.187
  5. A Randomized, Double-blinded, Placebo-controlled Trial of Sitagliptin for Reducing Inflammation and Immune Activation in Treated and Suppressed Human Immunodeficiency Virus Infection. Clin Infect Dis. 2019 09 13; 69(7):1165-1172.
    View in: PubMed
    Score: 0.164
  6. Cytokines Elevated in HIV Elite Controllers Reduce HIV Replication In Vitro and Modulate HIV Restriction Factor Expression. J Virol. 2017 03 15; 91(6).
    View in: PubMed
    Score: 0.138
  7. CXCR5(+) follicular cytotoxic T cells control viral infection in B cell follicles. Nat Immunol. 2016 10; 17(10):1187-96.
    View in: PubMed
    Score: 0.132
  8. Glucose transporter 1-expressing proinflammatory monocytes are elevated in combination antiretroviral therapy-treated and untreated HIV+ subjects. J Immunol. 2014 Dec 01; 193(11):5595-603.
    View in: PubMed
    Score: 0.117
  9. HIV RNA levels in plasma and cervical-vaginal lavage fluid in elite controllers and HAART recipients. AIDS. 2014 Mar 13; 28(5):739-43.
    View in: PubMed
    Score: 0.112
  10. Regulatory B cell frequency correlates with markers of HIV disease progression and attenuates anti-HIV CD8? T cell function in vitro. J Leukoc Biol. 2013 May; 93(5):811-8.
    View in: PubMed
    Score: 0.104
  11. Age-associated changes in monocyte and innate immune activation markers occur more rapidly in HIV infected women. PLoS One. 2013; 8(1):e55279.
    View in: PubMed
    Score: 0.104
  12. Towards an HIV cure: a global scientific strategy. Nat Rev Immunol. 2012 07 20; 12(8):607-14.
    View in: PubMed
    Score: 0.100
  13. A randomized trial of interleukin-2 during withdrawal of antiretroviral treatment. J Interferon Cytokine Res. 2011 Jun; 31(6):481-3.
    View in: PubMed
    Score: 0.090
  14. A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers. PLoS One. 2011 Jan 31; 6(1):e15924.
    View in: PubMed
    Score: 0.090
  15. Analysis of lymphocytes, monocytes, and neutrophils from human immunodeficiency virus (HIV)-infected persons for HIV DNA. J Infect Dis. 1990 Dec; 162(6):1239-44.
    View in: PubMed
    Score: 0.089
  16. Intracellular Casp8p41 content is inversely associated with CD4 T cell count. J Infect Dis. 2010 Aug 15; 202(3):386-91.
    View in: PubMed
    Score: 0.087
  17. Dysfunctional natural killer cells, in vivo, are governed by HIV viremia regardless of whether the infected individual is on antiretroviral therapy. AIDS. 2007 Nov 12; 21(17):2363-5.
    View in: PubMed
    Score: 0.072
  18. Correlation of serum HIV antigen and antibody with clinical status in HIV-infected patients. J Med Virol. 1987 Aug; 22(4):357-63.
    View in: PubMed
    Score: 0.071
  19. HIV infection of primary CD4+ Th2 cells, defined by expression of the chemoattractant receptor-homologous (CRTH2), induces a Th0 phenotype. AIDS Res Hum Retroviruses. 2007 Feb; 23(2):269-77.
    View in: PubMed
    Score: 0.068
  20. Interleukin-7 induces HIV replication in primary naive T cells through a nuclear factor of activated T cell (NFAT)-dependent pathway. Virology. 2006 Jul 05; 350(2):443-52.
    View in: PubMed
    Score: 0.064
  21. Sex Differences in Human Immunodeficiency Virus Persistence and Reservoir Size During Aging. Clin Infect Dis. 2022 08 24; 75(1):73-80.
    View in: PubMed
    Score: 0.050
  22. T-Cell Immune Dysregulation and Mortality in Women With Human Immunodeficiency Virus. J Infect Dis. 2022 02 15; 225(4):675-685.
    View in: PubMed
    Score: 0.049
  23. HIV immunology better understood and vaccination attempts started. AIDS. 2002; 16 Suppl 4:S85-8.
    View in: PubMed
    Score: 0.048
  24. Food Insecurity and T-cell Dysregulation in Women Living With Human Immunodeficiency Virus on Antiretroviral Therapy. Clin Infect Dis. 2021 03 01; 72(5):e112-e119.
    View in: PubMed
    Score: 0.045
  25. Altered Gut Microbiota and Host Metabolite Profiles in Women With Human Immunodeficiency Virus. Clin Infect Dis. 2020 12 03; 71(9):2345-2353.
    View in: PubMed
    Score: 0.045
  26. Mechanisms of HIV-associated lymphocyte apoptosis. Blood. 2000 Nov 01; 96(9):2951-64.
    View in: PubMed
    Score: 0.044
  27. CD8+ lymphocytes in pregnancy and HIV infection: characterization of CD8+ subpopulations and CD8+ noncytotoxic antiviral activity. AIDS Res Hum Retroviruses. 1999 May 01; 15(7):665-70.
    View in: PubMed
    Score: 0.040
  28. Hepatic fibrosis and immune phenotype vary by HCV viremia in HCV/HIV co-infected subjects: A Women's interagency HIV study. Medicine (Baltimore). 2016 Aug; 95(33):e4483.
    View in: PubMed
    Score: 0.033
  29. In vitro restoration of T cell immune function in human immunodeficiency virus-positive persons: effects of interleukin (IL)-12 and anti-IL-10. J Infect Dis. 1996 May; 173(5):1085-91.
    View in: PubMed
    Score: 0.032
  30. Microbiome alterations in HIV infection a review. Cell Microbiol. 2016 May; 18(5):645-51.
    View in: PubMed
    Score: 0.032
  31. Older age is associated with peripheral blood expansion of na?ve B cells in HIV-infected subjects on antiretroviral therapy. PLoS One. 2014; 9(9):e107064.
    View in: PubMed
    Score: 0.029
  32. Anti-cellular antibodies in sera from vaccinated macaques can induce complement-mediated virolysis of human immunodeficiency virus and simian immunodeficiency virus. Virology. 1993 Aug; 195(2):475-80.
    View in: PubMed
    Score: 0.027
  33. Complement activation by human monoclonal antibodies to human immunodeficiency virus. J Virol. 1993 Jan; 67(1):53-9.
    View in: PubMed
    Score: 0.026
  34. Human immunodeficiency virus (HIV)-infected cells and free virus directly activate the classical complement pathway in rabbit, mouse and guinea-pig sera; activation results in virus neutralization by virolysis. Immunology. 1991 Aug; 73(4):377-82.
    View in: PubMed
    Score: 0.023
  35. Activation of CD8 T cells predicts progression of HIV infection in women coinfected with hepatitis C virus. J Infect Dis. 2010 Mar 15; 201(6):823-34.
    View in: PubMed
    Score: 0.021
  36. Association of cells with natural killer (NK) and NKT immunophenotype with incident cancers in HIV-infected women. AIDS Res Hum Retroviruses. 2008 Feb; 24(2):163-8.
    View in: PubMed
    Score: 0.018
  37. Diagnosis of human immunodeficiency virus infection in seronegative homosexuals presenting with an acute viral syndrome. JAMA. 1987 Sep 04; 258(9):1196-9.
    View in: PubMed
    Score: 0.018
  38. HIV isolation from plasma of HIV-infected persons. N Engl J Med. 1987 Jun 11; 316(24):1547-8.
    View in: PubMed
    Score: 0.018
  39. Sensitivity and specificity of an HIV antibody assay. AIDS Res. 1986; 2(4):369-75.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.